Exagen Inc. (XGN): Long-Term Debt
$22.91M
As of 2025-12-31
$22.84M
As of 2026-06-30
-7.5%
3-year compound annual growth
-3.0%
5-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $22.91M | +13.1% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $20.25M | +3.8% | 2025-03-11, Balance as of period end |
| 2023-12-31 | $19.50M | -32.7% | 2024-03-18, Balance as of period end |
| 2022-12-31 | $28.97M | +5.4% | 2023-03-20, Balance as of period end |
| 2021-12-31 | $27.48M | +3.1% | 2022-03-22, Balance as of period end |
| 2020-12-31 | $26.66M | +3.1% | 2021-03-16, Balance as of period end |
| 2019-12-31 | $25.85M | n/a | 2020-03-25, Balance as of period end |
Long-Term Debt at similar companies
| Company | Year ended | Long-Term Debt | Change YoY |
|---|---|---|---|
| Exagen Inc. (XGN) | 2025-12-31 | $22.91M | +13.1% |
| Biodesix Inc (BDSX) | 2025-12-31 | $50.01M | +24.9% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $17.40M | -14.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $57.23M | +11.2% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $10.06M | +0.3% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $378.45M | +1.4% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $1.50B | +31.6% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $1.09B | +7.2% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $5.67B | -8.8% |
Compare XGN, BDSX, AMS, BLLN side by side · Screen every company in Services-Medical Laboratories ↗